GLP-1R is expressed in several brain regions, including the hippocampus and cortex, where it may influence synaptic plasticity, neuroinflammation, and cellular energy metabolism [88,89]
Tran S, Retnakaran R, Zinman B, Kramer CK (2018) Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: a meta-analysis of randomized clinical trials
This process, combined with the effects of GLP-1 Peptides, makes weight loss easier
This data suggests that while lower doses (5-15g) are excellent for maintenance and mild IBS, repairing severe, pathological "leaky gut" may require transient, high-dose interventions under medical supervision to rapidly force the reassembly of tight junction proteins
Less effective than Semaglutide for most patients
Global Reach: Our solutions for obesity clinical trials have engaged over 50,000 patients across 35 countries, with studies lasting up to 5 years